Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Inhibition of Pantothenate Synthetase by Analogs of β-Alanine Precursor Ineffective as an Antibacterial Strategy.

Liyanage SI, Gupta M, Wu F, Taylor M, Carter MD, Weaver DF.

Chemotherapy. 2019;64(1):22-27. doi: 10.1159/000499899. Epub 2019 Jun 5.

PMID:
31167192
2.

Understanding Water Structure in an Ion-Pair Solvation Shell in the Vicinity of a Water/Membrane Interface.

Oh MI, Gupta M, Weaver DF.

J Phys Chem B. 2019 May 9;123(18):3945-3954. doi: 10.1021/acs.jpcb.9b01331. Epub 2019 May 1.

PMID:
31009219
3.

In the Alzheimer waiting room.

Weaver DF.

CMAJ. 2018 Aug 20;190(33):E989-E990. doi: 10.1503/cmaj.180320. No abstract available.

4.

Nutrients in Alzheimer's Disease: The Interaction of Diet, Drugs and Disease.

Liyanage SI, Vilekar P, Weaver DF.

Can J Neurol Sci. 2019 Jan;46(1):23-34. doi: 10.1017/cjn.2018.353. Review.

PMID:
30688198
5.

The hidden variables problem in Alzheimer's disease clinical trial design.

Liyanage SI, Santos C, Weaver DF.

Alzheimers Dement (N Y). 2018 Nov 13;4:628-635. doi: 10.1016/j.trci.2018.09.003. eCollection 2018. Review.

6.

Point-of-care brain injury evaluation of conscious awareness: wide scale deployment of portable HCS EEG evaluation.

Fleck-Prediger CM, Ghosh Hajra S, Liu CC, Gray DS, Weaver DF, Gopinath S, Dick BD, D'Arcy RCN.

Neurosci Conscious. 2018 Nov 23;2018(1):niy011. doi: 10.1093/nc/niy011. eCollection 2018.

7.

Concussion, Cagney, Captains of the Clouds.

Weaver DF.

Can J Neurol Sci. 2018 Nov;45(6):682-685. doi: 10.1017/cjn.2018.332.

PMID:
30430965
8.

Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation.

Mancini RS, Wang Y, Weaver DF.

Front Neurosci. 2018 Oct 12;12:735. doi: 10.3389/fnins.2018.00735. eCollection 2018.

9.

Topically applied linoleic/linolenic acid for chronic migraine.

Santos C, Weaver DF.

J Clin Neurosci. 2018 Dec;58:200-201. doi: 10.1016/j.jocn.2018.10.013. Epub 2018 Oct 11.

PMID:
30316628
10.

Susceptibility to hippocampal kindling seizures is increased in aging C57 black mice.

Stover KR, Lim S, Zhou TL, Stafford PM, Chow J, Li H, Sivanenthiran N, Mylvaganam S, Wu C, Weaver DF, Eubanks J, Zhang L.

IBRO Rep. 2017 Sep 24;3:33-44. doi: 10.1016/j.ibror.2017.08.001. eCollection 2017 Dec.

11.

Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform.

Kolaj I, Imindu Liyanage S, Weaver DF.

Neurochem Int. 2018 Nov;120:99-111. doi: 10.1016/j.neuint.2018.08.001. Epub 2018 Aug 8. Review.

PMID:
30098379
12.

Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold.

Brant MG, Goodwin-Tindall J, Stover KR, Stafford PM, Wu F, Meek AR, Schiavini P, Wohnig S, Weaver DF.

ACS Med Chem Lett. 2018 Jan 11;9(2):131-136. doi: 10.1021/acsmedchemlett.7b00488. eCollection 2018 Feb 8.

13.

Lingua patientis: new words for patient communication and history taking.

Weaver DF.

Scott Med J. 2017 Nov;62(4):147-148. doi: 10.1177/0036933017743167. Epub 2017 Dec 7.

PMID:
29214906
14.

Disruptive technology disorder: A past, present, and future neurologic syndrome.

Weaver DF.

Neurology. 2017 Jul 25;89(4):395-398. doi: 10.1212/WNL.0000000000004095.

PMID:
28739662
15.

The Bingo Card Sign as an Early Symptom of Alzheimer's Disease.

Hawco CLA, Weaver DF.

Ir Med J. 2017 Apr 10;110(4):551.

PMID:
28665090
16.

Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides.

Russell S, Rahmani R, Jones AJ, Newson HL, Neilde K, Cotillo I, Rahmani Khajouei M, Ferrins L, Qureishi S, Nguyen N, Martinez-Martinez MS, Weaver DF, Kaiser M, Riley J, Thomas J, De Rycker M, Read KD, Flematti GR, Ryan E, Tanghe S, Rodriguez A, Charman SA, Kessler A, Avery VM, Baell JB, Piggott MJ.

J Med Chem. 2016 Nov 10;59(21):9686-9720. Epub 2016 Sep 19.

17.

Diversification of edaravone via palladium-catalyzed hydrazine cross-coupling: Applications against protein misfolding and oligomerization of beta-amyloid.

MacLean MA, Diez-Cecilia E, Lavery CB, Reed MA, Wang Y, Weaver DF, Stradiotto M.

Bioorg Med Chem Lett. 2016 Jan 1;26(1):100-4. doi: 10.1016/j.bmcl.2015.11.022. Epub 2015 Nov 10.

PMID:
26598460
18.

A Maple Syrup Extract Prevents β-Amyloid Aggregation.

Hawco CL, Wang Y, Taylor M, Weaver DF.

Can J Neurol Sci. 2016 Jan;43(1):198-201. doi: 10.1017/cjn.2015.270. Epub 2015 Sep 3. No abstract available.

PMID:
26336085
19.

Geminate consonant grapheme-colour synaesthesia (ideaesthesia).

Weaver DF, Hawco CL.

BMC Neurol. 2015 Jul 15;15:112. doi: 10.1186/s12883-015-0372-7.

20.

Impact of protecting ligands on surface structure and antibacterial activity of silver nanoparticles.

Padmos JD, Boudreau RT, Weaver DF, Zhang P.

Langmuir. 2015 Mar 31;31(12):3745-52. doi: 10.1021/acs.langmuir.5b00049. Epub 2015 Mar 20.

PMID:
25773131
21.

Font specific reading-induced seizures.

Weaver DF.

Clin Neurol Neurosurg. 2014 Oct;125:210-1. doi: 10.1016/j.clineuro.2014.07.035. Epub 2014 Aug 20. No abstract available.

PMID:
25178914
22.

Drug design and discovery: translational biomedical science varies among countries.

Weaver IN, Weaver DF.

Clin Transl Sci. 2013 Oct;6(5):409-13. doi: 10.1111/cts.12058. Epub 2013 Apr 19.

23.

Vagal stimulation by manual carotid sinus massage to acutely suppress seizures.

Laine Green A, Weaver DF.

J Clin Neurosci. 2014 Jan;21(1):179-80. doi: 10.1016/j.jocn.2013.03.017. Epub 2013 Aug 17.

PMID:
23962632
24.

An Evaluation of Interindividual Responses to the Orally Administered Neurotransmitter β -Alanine.

Macphee S, Weaver IN, Weaver DF.

J Amino Acids. 2013;2013:429847. doi: 10.1155/2013/429847. Epub 2013 Jun 23.

25.

Pharmacoresistant epilepsy: unmet needs in solving the puzzle(s).

Weaver DF, Pohlmann-Eden B.

Epilepsia. 2013 May;54 Suppl 2:80-5. doi: 10.1111/epi.12191. Review.

26.

Design of innovative therapeutics for pharmacoresistant epilepsy: challenges and needs.

Weaver DF.

Epilepsia. 2013 May;54 Suppl 2:56-9. doi: 10.1111/epi.12185. Review.

27.

The puzzle(s) of pharmacoresistant epilepsy.

Pohlmann-Eden B, Weaver DF.

Epilepsia. 2013 May;54 Suppl 2:1-4. doi: 10.1111/epi.12174.

28.
29.

Exploring neurotherapeutic space: how many neurological drugs exist (or could exist)?

Weaver DF, Weaver CA.

J Pharm Pharmacol. 2011 Jan;63(1):136-9.

PMID:
21189659
30.

Towards brain first-aid: a diagnostic device for conscious awareness.

D'Arcy RC, Hajra SG, Liu C, Sculthorpe LD, Weaver DF.

IEEE Trans Biomed Eng. 2011 Mar;58(3):750-4. doi: 10.1109/TBME.2010.2090880. Epub 2010 Nov 11.

PMID:
21075716
31.

The development of new therapeutics for Alzheimer's disease.

Carter MD, Simms GA, Weaver DF.

Clin Pharmacol Ther. 2010 Oct;88(4):475-86. doi: 10.1038/clpt.2010.165. Epub 2010 Sep 1. Review.

PMID:
20811351
32.

Science as a human value.

Weaver DF.

Can J Neurol Sci. 2010 Jul;37(4):539-40. No abstract available.

PMID:
20724269
33.

Beta-alanine as a small molecule neurotransmitter.

Tiedje KE, Stevens K, Barnes S, Weaver DF.

Neurochem Int. 2010 Oct;57(3):177-88. doi: 10.1016/j.neuint.2010.06.001. Epub 2010 Jun 9. Review.

PMID:
20540981
34.

The bioisosteric similarity of the tetrazole and carboxylate anions: clues from the topologies of the electrostatic potential and of the electron density.

Matta CF, Arabi AA, Weaver DF.

Eur J Med Chem. 2010 May;45(5):1868-72. doi: 10.1016/j.ejmech.2010.01.025. Epub 2010 Jan 20.

PMID:
20133027
35.

Improving the clinical assessment of consciousness with advances in electrophysiological and neuroimaging techniques.

Gawryluk JR, D'Arcy RC, Connolly JF, Weaver DF.

BMC Neurol. 2010 Jan 29;10:11. doi: 10.1186/1471-2377-10-11. Review.

36.

The rise of micropharma.

Barden CJ, Weaver DF.

Drug Discov Today. 2010 Feb;15(3-4):84-7. doi: 10.1016/j.drudis.2009.10.001. Epub 2009 Oct 28.

PMID:
19837185
37.

Self-induced "therapeutic seizures" for the treatment of depression.

Weaver DF.

J Neuropsychiatry Clin Neurosci. 2009 Summer;21(3):355-6. doi: 10.1176/appi.neuropsych.21.3.355. No abstract available.

PMID:
19776330
38.

Don't overlook the rigorously reviewed novel work in patents.

Weaver DF, Barden C.

Nature. 2009 Sep 17;461(7262):340. doi: 10.1038/461340b. No abstract available.

PMID:
19759596
39.

Reflections: Neurology and the humanities. Perception of time.

Weaver DF.

Neurology. 2008 Nov 25;71(22):1836-7. doi: 10.1212/01.wnl.0000340780.22816.19. No abstract available.

PMID:
19029527
40.

Deducing the bioactive face of hydantoin anticonvulsant drugs using NMR spectroscopy.

Tiedje KE, Weaver DF.

Can J Neurol Sci. 2008 May;35(2):232-6.

PMID:
18574940
41.

Potential proconvulsant effects of oral zinc supplementation: a case report.

Green AL, Weaver DF.

Neurotoxicology. 2008 May;29(3):476-7. doi: 10.1016/j.neuro.2008.03.008. Epub 2008 Apr 7. No abstract available.

PMID:
18468689
42.

Does NSAID use modify cognitive trajectories in the elderly? The cache county study.

Weaver DF, Carter MD.

Neurology. 2008 Mar 11;70(11):895. doi: 10.1212/01.wnl.0000307673.96325.ab. No abstract available.

PMID:
18332350
43.

Recent advances in research on radiofrequency fields and health: 2001-2003.

Krewski D, Glickman BW, Habash RW, Habbick B, Lotz WG, Mandeville R, Prato FS, Salem T, Weaver DF.

J Toxicol Environ Health B Crit Rev. 2007 Jun-Jul;10(4):287-318. Review.

PMID:
17620203
44.

Anaesthetic binding sites for etomidate and propofol on a GABAA receptor model.

Campagna-Slater V, Weaver DF.

Neurosci Lett. 2007 May 11;418(1):28-33. Epub 2007 Mar 19.

PMID:
17412502
45.

Epilepsy and antiepileptic drug use in elderly people as risk factors for dementia.

Carter MD, Weaver DF, Joudrey HR, Carter AO, Rockwood K.

J Neurol Sci. 2007 Jan 31;252(2):169-72. Epub 2006 Dec 19.

PMID:
17182059
46.

Molecular modelling of the GABAA ion channel protein.

Campagna-Slater V, Weaver DF.

J Mol Graph Model. 2007 Jan;25(5):721-30. Epub 2006 Jun 17.

PMID:
16877018
47.

Evaluating spousal abuse as a potential risk factor for Alzheimer's disease: rationale, needs and challenges.

Leung FH, Thompson K, Weaver DF.

Neuroepidemiology. 2006;27(1):13-6. Epub 2006 Jun 13.

PMID:
16770080
48.
49.

Designing future drugs for the treatment of intractable epilepsy.

Weaver DF.

Adv Neurol. 2006;97:429-34. Review. No abstract available.

PMID:
16383153
50.

Supplemental Content

Loading ...
Support Center